Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Antibody / Recombinant Antibody

Anti-CMTM6 Antibody (R4C56)

Catalog #:   RHP03101 Specific References (10) DATASHEET
Host species: Mouse
Isotype: IgG1
Applications: IHC, IP, WB
Accession: Q9NX76
Overview

Catalog No.

RHP03101

Species reactivity

Human

Host species

Mouse

Isotype

IgG1

Clonality

Monoclonal

Tested applications

IHC: 1:500, IP: 1:100-1:200, WB: 1:500-1:1000

Target

CKLF-like MARVEL transmembrane domain-containing protein 6, Chemokine-like factor superfamily member 6, CKLFSF6, CMTM6

Concentration

1 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% as determined by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Accession

Q9NX76

Applications

IHC, IP, WB

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4, 0.05% Sodium Azide.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.

Clone ID

R4C56

Data Image
  • Immunohistochemical
    IHC-P analysis of endometrium tissue by CMTM6 antibody (RHP03101). Immunohistochemistry was performed using sections of formalin-fixed paraffin- embedded endometrium tissue;Result: Glandular cells are positively stained at the cell membrane.
  • Immunoprecipitation
    Lane 1: Jurkat lysate; Lane 2: CMTM6 immunoprecipitated from Jurkat lysate by RHP03101;Lane 3: The same as Lane 2 but use IgG isotype control antibody;Result: RHP03101 can immunoprecipitate CMTM6;
  • Western blot
    Western blot analysis using CMTM6 mouse mAb against Jurkat lysate
References

Hsc70 promotes anti-tumor immunity by targeting PD-L1 for lysosomal degradation., PMID:38762492

CMTM6 overexpression confers trastuzumab resistance in HER2-positive breast cancer., PMID:36627608

Construction of stable membranal CMTM6-PD-L1 full-length complex to evaluate the PD-1/PD-L1-CMTM6 interaction and develop anti-tumor anti-CMTM6 nanobody., PMID:36418428

CMTM6-Deficient Monocytes in ANCA-Associated Vasculitis Fail to Present the Immune Checkpoint PD-L1., PMID:34108971

Possible effects of chemokine-like factor-like MARVEL transmembrane domain-containing family on antiphospholipid syndrome., PMID:33813507

WEE1 inhibition reverses trastuzumab resistance in HER2-positive cancers., PMID:33723720

HuR up-regulates cell surface PD-L1 via stabilizing CMTM6 transcript in cancer., PMID:33649535

Expression Analysis of Canine CMTM6 and CMTM4 as Potential Regulators of the PD-L1 Protein in Canine Cancers., PMID:32596272

PD-L1 (B7-H1) Competes with the RNA Exosome to Regulate the DNA Damage Response and Can Be Targeted to Sensitize to Radiation or Chemotherapy., PMID:31053471

A novel 3p22.3 gene CMTM7 represses oncogenic EGFR signaling and inhibits cancer cell growth., PMID:23893243

Datasheet

Document Download

Anti-CMTM6 Antibody (R4C56).pdf

 

$ 220
Product specifications
50 μg 220 100 μg 350

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-CMTM6 Antibody (R4C56) [RHP03101]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only